TRIPAWDS: Home to 22969 Members and 2152 Blogs.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG

Caring for a Three Legged Dog or Cat

Tripawds is your home to learn how to care for a three legged dog or cat, with answers about dog leg amputation, and cat amputation recovery from many years of member experiences.

JUMP TO FORUMS

Join The Tripawds Community

Learn how to help three legged dogs and cats in the forums below. Browse and search as a guest or register for free and get full member benefits:

Instant post approval.

Private messages to members.

Subscribe to favorite topics.

Live Chat and much more!

Please consider registering
Guest
Search
Forum Scope


Match



Forum Options



Minimum search word length is 3 characters - maximum search word length is 84 characters
Register Lost password?
sp_Feed sp_PrintTopic sp_TopicIcon-c
DR Sue posted about a milestone for Canine Lymphoma.
sp_NewTopic Add Topic




Member Since:
16 October 2012
sp_UserOfflineSmall Offline
1
24 August 2016 - 6:27 pm
sp_Permalink sp_Print sp_EditHistory sp_QuotePost

Dr Sue posted this about a Lymphoma treatment   http://www.busi.....4005909/en

VetDC Achieves Key Regulatory Milestone, Nears FDA Approval of TANOVEA for Canine Lymphoma

August 24, 2016 01:30 PM Eastern Daylight Time
FORT COLLINS, Colo.--(BUSINESS WIRE)--VetDC, Inc., a veterinary cancer therapeutics company, today announced that the Company has received three major technical section complete letters for TanoveaTM (rabacfosadine) from the U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM). Upon approval, Tanovea will be the first on-label therapeutic option for use in dogs with lymphoma, one of the most common cancers afflicting companion animals today.

“This is a significant milestone for VetDC, as we are one step closer to introducing the first FDA-approved drug for use in dogs with lymphoma”

Tweet this

The three major technical section complete letters are required to file an administrative New Animal Drug Application for approval with the FDA-CVM. VetDC plans to submit the administrative filing later this year. Once Tanovea receives FDA approval, VetDC intends to commence commercialization in early 2017.

“This is a significant milestone for VetDC, as we are one step closer to introducing the first FDA-approved drug for use in dogs with lymphoma,” stated Steven Roy, VetDC’s President and CEO. “There is a clear unmet need for new therapeutic alternatives to address this common and devastating cancer in pets. Given Tanovea’s demonstrated anti-tumor effects, rapid onset of action, generally well–tolerated profile and a substantial reduction in pet owner visits to the veterinarian, our market research suggests that Tanovea has the potential to achieve peak sales of at least $40 million annually in a rapidly growing market.”

About Tanovea

TanoveaTM (rabacfosadine) is a novel small molecule drug designed to preferentially target and attack cancer cells implicated in lymphoma, one of the most common and deadly cancers impacting pets today. In multiple clinical studies in over 300 client-owned dogs with naturally occurring lymphoma, Tanovea has consistently demonstrated substantial anti-tumor activity in both naïve and relapsed cases, with a generally well-tolerated safety profile. Tanovea has a rapid onset of action, with responses observed in as few as 7 to 21 days. Tanovea is being investigated as a convenient, every-three-week treatment for up to five doses, representing a substantial reduction in client visits relative to non-approved ‘human’ generic chemotherapy regimens commonly utilized in dogs.

VetDC has an exclusive North American license from Gilead Sciences to develop and commercialize Tanovea for companion animal cancer.

About VetDC, Inc.

VetDC (http://www.vetdc.com) is changing the way new cancer medicines are developed for companion animals, leveraging novel advancements from human biotechnology that have demonstrated success in animal studies. VetDC currently has two programs in development, Tanovea for lymphoma and VDC-597 for multiple cancers.

sassymichelle-sm.jpg

Sassy is a proud member of the Winter Warriors. Live long, & strong Winter Warriors.
sassysugarbear.tripawds.com
07/26/2006 - Sassy earned her wings 08/20/2013

05/04/2006 -  Bosch, Sassy's pal, earned his wings 03/29/19  fought cancer for 4 months.

"You aren't doing it TO her, you are doing it FOR her. Give her a chance at life."

Virginia







Member Since:
22 February 2013
sp_UserOfflineSmall Offline
2
24 August 2016 - 8:01 pm
sp_Permalink sp_Print sp_QuotePost

THANJS MICHELLE!! We need all the " hooe for a better ttomorrow" we can get!

Who knows, if this works for one form, it may well be proven in the future to work for other kinds.!

You da' bomb!!

Happy Hannah had a glorious additional bonus time of over one yr & two months after amp for osteo! She made me laugh everyday! Joined April's Angels after send off meal of steak, ice cream, M&Ms & deer poop!

On The Road


Member Since:
24 September 2009
sp_UserOfflineSmall Offline
3
25 August 2016 - 10:34 am
sp_Permalink sp_Print sp_QuotePost

YAY! I love news like this, it's what keeps us hopeful that treatments like this will lead to cures for all cancers. WOOHOO!

Tripawds Founders Jim and Rene
tripawds.com | tripawds.org | bemoredog.net | triday.pet

Forum Timezone: America/Denver
Most Users Ever Online: 946
Currently Online:
Guest(s) 181
Currently Browsing this Page:
1 Guest(s)
Member Stats:
Guest Posters: 1268
Members: 17731
Moderators: 6
Admins: 3
Forum Stats:
Groups: 4
Forums: 24
Topics: 18610
Posts: 256797
Administrators: admin, jerry, Tripawds
Tripawds is brought to you by Tripawds.
HOME » NEWS » BLOGS » FORUMS » CHAT » YOUR PRIVACY » RANDOM BLOG